Business Context and Reporting Period
Company: Equus II Incorporated (a Delaware corporation and Business Development Company)
Reporting Period: Quarterly period ended March 31, 1997
Business Overview: The Fund seeks capital appreciation by investing in equity and equity-oriented securities of privately-owned companies, primarily in leveraged buyouts and recapitalizations. It is registered under the Investment Company Act of 1940 and trades on the American Stock Exchange (Symbol: EQS).
Key Financial Metrics
| Metric | Q1 1997 | Q1 1996 |
|---|---|---|
| Total Assets | $187,232,889 | $181,116,399 |
| Net Assets | $104,816,780 | $73,100,548 |
| Net Asset Value (NAV) per Share | $24.37 | $23.29 |
| Total Investment Income | $563,728 | $509,359 |
| Total Expenses | $1,381,887 | $3,615,335 |
| Net Investment Loss | $(818,159) | $(3,105,976) |
| Realized Gain (Loss) | $(3,935,954) | $1,285,835 |
| Unrealized Appreciation (Net) | $48,019,049 | $21,042,668 |
| Net Cash from Operating Activities | $56,299 | $(514,939) |
| Notes Payable to Bank | $70,400,000 | $65,300,000 |
| Temporary Cash Investments | $65,498,239 | $58,180,978 |
Material Changes vs. Prior Period
- Expense Reduction: Total expenses decreased significantly from $3.62 million in Q1 1996 to $1.38 million in Q1 1997. This was primarily driven by a reduction in deferred management incentive fees (from $2.77 million to $0.43 million) and lower interest expense (from $240,555 to $77,767) due to lower average daily loan balances.
- Realized Losses: The Fund recorded a net realized loss of $3.94 million in Q1 1997, compared to a gain of $1.29 million in Q1 1996. The 1997 loss was largely due to the sale of the Midway Airlines investment.
- Unrealized Gains: Net unrealized appreciation increased by $6.35 million in Q1 1997, compared to an increase of $13.07 million in Q1 1996.
- Liquidity: Operating cash flow turned positive ($56,299) in Q1 1997, reversing a negative flow of $(514,939) in the prior year, largely due to increased interest received from portfolio companies.
Guidance, Outlook, and Material Events
- Management Agreement Change: On April 9, 1997, shareholders approved a new management agreement that eliminates incentive fees based on capital gains. The existing deferred incentive fee of $11.21 million will be paid in the second quarter of 1997 via the issuance of 459,973 unregistered shares of common stock.
- Subsequent Sales: Post-period, the Fund sold its investment in David's Supermarkets, Inc. for $5.55 million, realizing a net capital gain of $1.48 million.
- New Investments: In April and May 1997, the Fund made new investments in Cardiovascular Ventures, Inc., Hot & Cool Holdings, Inc., Healthcare Technology Delivery, Inc., AVIAN Healthcare Corporation, and Atlas Acquisition, Inc.
- Debt Repayment: Subsequent to March 31, 1997, the Fund repaid a net $68.64 million of notes payable to the bank.
- Legal Contingencies: An amended shareholder derivative action was filed in January 1997 alleging breaches of fiduciary duty. Management believes the resolution will not have a material adverse effect on the Fund.
- Dividends: No dividends were declared for the quarter. The Fund maintains a policy to distribute at least $0.50 per share annually.
Investor Verification Checklist
- Deferred Fee Settlement: Verify the issuance of 459,973 shares to settle the $11.21 million deferred incentive fee and its impact on share count and dilution.
- Valuation Discounts: Review the $20.1 million discount applied to publicly traded securities to reflect sale restrictions, as this significantly impacts reported fair value.
- Debt Structure: Confirm the terms of the $30 million revolving line of credit and the $65 million promissory note, noting the extension to April 1998.
- Portfolio Concentration: Assess the risk associated with the Fund's controlling interests in several portfolio companies (e.g., Brazos Sportswear, Drypers Corporation) and the lack of public financial data for private holdings.
- Subsequent Realized Gains: Account for the $1.48 million gain on the David's Supermarkets sale which occurred after the reporting period.